Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Revenue

Tango Therapeutics had revenue of $53.81M in the quarter ending September 30, 2025, with 363.61% growth. This brings the company's revenue in the last twelve months to $66.50M, up 53.28% year-over-year. In the year 2024, Tango Therapeutics had annual revenue of $42.07M with 15.17% growth.

• Revenue (ttm): $66.50M
• Revenue Growth: +53.28%
• P/S Ratio: 26.08
• Revenue / Employee: $429,039
• Employees: 155
• Market Cap: 1.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	42.07M	5.54M	15.17%
Dec 31, 2023	36.53M	11.67M	46.93%
Dec 31, 2022	24.86M	-12.18M	-32.89%
Dec 31, 2021	37.04M	29.39M	383.83%
Dec 31, 2020	7.66M	-16.99M	-68.94%
Dec 31, 2019	24.65M	-	-